SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-21-031584
Filing Date
2021-06-09
Accepted
2021-06-09 08:06:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea142399-424b3_xtlbiopharma.htm 424B3 316367
2 GRAPHIC image_001.jpg GRAPHIC 25303
  Complete submission text file 0001213900-21-031584.txt   352335
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 424B3 | Act: 33 | File No.: 333-208817 | Film No.: 211004027
SIC: 2834 Pharmaceutical Preparations